FINWIRES · TerminalLIVE
FINWIRES

オッペンハイマー氏によると、チーズケーキファクトリーは2026年の市場予想に反する「興味深い」戦略をとっている。

-- オッペンハイマー証券は火曜日、チーズケーキファクトリー(CAKE)の2026年の業績見通しは、既存店売上高とEPS(1株当たり利益)の予測が保守的に下方修正されていることから、市場コンセンサスに対して「興味深い」状況にあると指摘した。 同証券によると、チーズケーキファクトリーの中核顧客は、業界全体に影響を与えるマクロ経済圧力の影響を受けていない。この状況とオッペンハイマー証券による市場コンセンサス分析は、ウォール街の第1四半期および第2四半期の既存店売上高予測(それぞれ0.6%と0.7%)に対して、同社にとって有利な状況を示している。 同証券は、ウォール街の2026年通期既存店売上高予測(1.1%)に対して、リスク・リターン比率が有利に傾いていると考えている。四半期ごとの既存店売上高予測は、健全な基調的な勢い、新たな企業固有の要因、そして比較対象の比較が容易であることなどを織り込んでいる可能性があると、同証券は付け加えた。 経営陣の第1四半期ガイダンスは、既存店売上高の中間値を1%、EPSを1ドル近辺と示唆していた。一方、オッペンハイマーは、SSS(売上高成長率)を1.0%、EPS(1株当たり利益)を1.01ドルと予測しており、市場コンセンサスの0.6%と1ドルを上回っています。 同証券会社は、2026年と2027年のEPS予想をそれぞれ4.03ドルと4.46ドルから4.04ドルと4.48ドルに若干引き上げました。 同社は4月29日に第1四半期決算を発表する予定です。 オッペンハイマーは、チーズケーキファクトリーの投資判断を「アウトパフォーム」に据え置き、目標株価を68ドルから72ドルに引き上げました。

Price: $61.90, Change: $-0.24, Percent Change: -0.39%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB